mRNA Synthesis and Manufacturing Market

Table of Content

1. Executive Summary

    1.1. Global mRNA Synthesis and Manufacturing Market Snapshot, 2024 and 2031

    1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events 

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Key Trends

    2.3. Macro-Economic Factors

        2.3.1. Global Sectorial Outlook

        2.3.2. Global GDP Growth Outlook

        2.3.3. Global Healthcare Spending Outlook

    2.4. COVID-19 Impact Analysis

    2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights 

    3.1. Product Adoption Analysis

    3.2. Technology Assessment

    3.3. Regulatory Landscape

    3.4. Supply Chain Analysis

    3.5. Key Deals and Mergers

    3.6. PESTLE Analysis

    3.7. Porter's Five Force Analysis 

4. Global mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    4.1. Key Highlights

        4.1.1. Market Size (US$ Mn) and Y-o-Y Growth

        4.1.2. Absolute $ Opportunity

    4.2. Market Size (US$ Mn) Analysis and Forecast

        4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022

        4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031

    4.3. Global mRNA Synthesis and Manufacturing Market Outlook: Service Type

        4.3.1. Introduction / Key Findings

        4.3.2. Historical Market Size (US$ Mn) Analysis, By Service Type, 2018 - 2022

        4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

            4.3.3.1. mRNA Drug Synthesis

            4.3.3.2. mRNA Vaccine Synthesis

    4.4. Market Attractiveness Analysis: Service Type

    4.5. Global mRNA Synthesis and Manufacturing Market Outlook: Scale of Operation

        4.5.1. Introduction / Key Findings

        4.5.2. Historical Market Size (US$ Mn) Analysis, By Scale of Operation, 2018 - 2022

        4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

            4.5.3.1. Preclinical

            4.5.3.2. Clinical

            4.5.3.3. Commercial

    4.6. Market Attractiveness Analysis: Scale of Operation

    4.7. Global mRNA Synthesis and Manufacturing Market Outlook: Therapeutic Area

        4.7.1. Introduction / Key Findings

        4.7.2. Historical Market Size (US$ Mn) Analysis, By Therapeutic Area, 2018 - 2022

        4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

            4.7.3.1. Infectious Diseases

            4.7.3.2. Oncology

            4.7.3.3. Others

    4.8. Market Attractiveness Analysis: Therapeutic Area

    4.9. Global mRNA Synthesis and Manufacturing Market Outlook: Application

        4.9.1. Introduction / Key Findings

        4.9.2. Historical Market Size (US$ Mn) Analysis, By Application, 2018 - 2022

        4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

            4.9.3.1. Vaccine Production

            4.9.3.2. Therapeutic Development

            4.9.3.3. Drug Discovery

            4.9.3.4. Others

    4.10. Market Attractiveness Analysis: Application

5. Global mRNA Synthesis and Manufacturing Market Outlook: Region

    5.1. Key Highlights

    5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022

    5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031

        5.3.1. North America

        5.3.2. Europe

        5.3.3. East Asia

        5.3.4. South Asia and Oceania

        5.3.5. Latin America

        5.3.6. Middle East & Africa

    5.4. Market Attractiveness Analysis: Region

6. North America mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031) 

    6.1. Key Highlights

    6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        6.2.1. By Country

        6.2.2. By Service Type

        6.2.3. By Scale of Operation

        6.2.4. By Therapeutic Area

        6.2.5. By Application

    6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        6.3.1. U.S.

        6.3.2. Canada

    6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        6.4.1. mRNA Drug Synthesis

        6.4.2. mRNA Vaccine Synthesis

    6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        6.5.1. Preclinical

        6.5.2. Clinical

        6.5.3. Commercial

    6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        6.6.1. Infectious Diseases

        6.6.2. Oncology

        6.6.3. Others

    6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        6.7.1. Vaccine Production

        6.7.2. Therapeutic Development

        6.7.3. Drug Discovery

        6.7.4. Others

    6.8. Market Attractiveness Analysis

7. Europe mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    7.1. Key Highlights

    7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        7.2.1. By Country

        7.2.2. By Service Type

        7.2.3. By Scale of Operation

        7.2.4. By Therapeutic Area

        7.2.5. By Application

    7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        7.3.1. Germany

        7.3.2. France

        7.3.3. U.K.

        7.3.4. Italy

        7.3.5. Spain

        7.3.6. Russia

        7.3.7. Türkiye

        7.3.8. Rest of Europe

    7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        7.4.1. mRNA Drug Synthesis

        7.4.2. mRNA Vaccine Synthesis

    7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        7.5.1. Preclinical

        7.5.2. Clinical

        7.5.3. Commercial

    7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        7.6.1. Infectious Diseases

        7.6.2. Oncology

        7.6.3. Others

    7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        7.7.1. Vaccine Production

        7.7.2. Therapeutic Development

        7.7.3. Drug Discovery

        7.7.4. Others

    7.8. Market Attractiveness Analysis

8. East Asia mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    8.1. Key Highlights

    8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        8.2.1. By Country

        8.2.2. By Service Type

        8.2.3. By Scale of Operation

        8.2.4. By Therapeutic Area

        8.2.5. By Application

    8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        8.3.1. China

        8.3.2. Japan

        8.3.3. South Korea

    8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        8.4.1. mRNA Drug Synthesis

        8.4.2. mRNA Vaccine Synthesis

    8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        8.5.1. Preclinical

        8.5.2. Clinical

        8.5.3. Commercial

    8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        8.6.1. Infectious Diseases

        8.6.2. Oncology

        8.6.3. Others

    8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        8.7.1. Vaccine Production

        8.7.2. Therapeutic Development

        8.7.3. Drug Discovery

        8.7.4. Others

    8.8. Market Attractiveness Analysis

9. South Asia & Oceania mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    9.1. Key Highlights

    9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        9.2.1. By Country

        9.2.2. By Service Type

        9.2.3. By Scale of Operation

        9.2.4. By Therapeutic Area

        9.2.5. By Application

    9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        9.3.1. India

        9.3.2. Southeast Asia

        9.3.3. ANZ

        9.3.4. Rest of South Asia & Oceania

    9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        9.4.1. mRNA Drug Synthesis

        9.4.2. mRNA Vaccine Synthesis

    9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        9.5.1. Preclinical

        9.5.2. Clinical

        9.5.3. Commercial

    9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        9.6.1. Infectious Diseases

        9.6.2. Oncology

        9.6.3. Others

    9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        9.7.1. Vaccine Production

        9.7.2. Therapeutic Development

        9.7.3. Drug Discovery

        9.7.4. Others

    9.8. Market Attractiveness Analysis

10. Latin America mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    10.1. Key Highlights

    10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        10.2.1. By Country

        10.2.2. By Service Type

        10.2.3. By Scale of Operation

        10.2.4. By Therapeutic Area

        10.2.5. By Application

    10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        10.3.1. Brazil

        10.3.2. Mexico

        10.3.3. Rest of Latin America

    10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        10.4.1. mRNA Drug Synthesis

        10.4.2. mRNA Vaccine Synthesis

    10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        10.5.1. Preclinical

        10.5.2. Clinical

        10.5.3. Commercial

    10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        10.6.1. Infectious Diseases

        10.6.2. Oncology

        10.6.3. Others

    10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        10.7.1. Vaccine Production

        10.7.2. Therapeutic Development

        10.7.3. Drug Discovery

        10.7.4. Others

    10.8. Market Attractiveness Analysis

11. Middle East & Africa mRNA Synthesis and Manufacturing Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)

    11.1. Key Highlights

    11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022

        11.2.1. By Country

        11.2.2. By Service Type

        11.2.3. By Scale of Operation

        11.2.4. By Therapeutic Area

        11.2.5. By Application

    11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031

        11.3.1. GCC Countries

        11.3.2. Egypt

        11.3.3. South Africa

        11.3.4. Northern Africa

        11.3.5. Rest of Middle East & Africa

    11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2023 - 2031

        11.4.1. mRNA Drug Synthesis

        11.4.2. mRNA Vaccine Synthesis

    11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Scale of Operation, 2023 - 2031

        11.5.1. Preclinical

        11.5.2. Clinical

        11.5.3. Commercial

    11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Therapeutic Area, 2023 - 2031

        11.6.1. Infectious Diseases

        11.6.2. Oncology

        11.6.3. Others

    11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031

        11.7.1. Vaccine Production

        11.7.2. Therapeutic Development

        11.7.3. Drug Discovery

        11.7.4. Others

    11.8. Market Attractiveness Analysis

12. Competition Landscape

    12.1. Market Share Analysis, 2023

    12.2. Market Structure

        12.2.1. Competition Intensity Mapping By Market 

        12.2.2. Competition Dashboard

    12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        12.3.1. DH Life Sciences, LLC (Danaher)

            12.3.1.1. Overview

            12.3.1.2. Segments and Products

            12.3.1.3. Key Financials

            12.3.1.4. Market Developments

            12.3.1.5. Market Strategy

        12.3.2. Azenta Life Sciences (Genewiz)

            12.3.2.1. Overview

            12.3.2.2. Segments and Products

            12.3.2.3. Key Financials

            12.3.2.4. Market Developments

            12.3.2.5. Market Strategy

        12.3.3. Merck KGaA

            12.3.3.1. Overview

            12.3.3.2. Segments and Products

            12.3.3.3. Key Financials

            12.3.3.4. Market Developments

            12.3.3.5. Market Strategy

        12.3.4. TriLink BioTechnologies

            12.3.4.1. Overview

            12.3.4.2. Segments and Products

            12.3.4.3. Key Financials

            12.3.4.4. Market Developments

            12.3.4.5. Market Strategy

        12.3.5. GenScript

            12.3.5.1. Overview

            12.3.5.2. Segments and Products

            12.3.5.3. Key Financials

            12.3.5.4. Market Developments

            12.3.5.5. Market Strategy

        12.3.6. Creative Biolabs

            12.3.6.1. Overview

            12.3.6.2. Segments and Products

            12.3.6.3. Key Financials

            12.3.6.4. Market Developments

            12.3.6.5. Market Strategy

        12.3.7. Thermo Fisher Scientific Inc.

            12.3.7.1. Overview

            12.3.7.2. Segments and Products

            12.3.7.3. Key Financials

            12.3.7.4. Market Developments

            12.3.7.5. Market Strategy

        12.3.8. BOC Sciences

            12.3.8.1. Overview

            12.3.8.2. Segments and Products

            12.3.8.3. Key Financials

            12.3.8.4. Market Developments

            12.3.8.5. Market Strategy

        12.3.9. Takara Bio Inc. 

            12.3.9.1. Overview

            12.3.9.2. Segments and Products

            12.3.9.3. Key Financials

            12.3.9.4. Market Developments

            12.3.9.5. Market Strategy

        12.3.10. Kaneka Eurogentec S.A

            12.3.10.1. Overview

            12.3.10.2. Segments and Products

            12.3.10.3. Key Financials

            12.3.10.4. Market Developments

            12.3.10.5. Market Strategy

        12.3.11. WuXi Biologics

            12.3.11.1. Overview

            12.3.11.2. Segments and Products

            12.3.11.3. Key Financials

            12.3.11.4. Market Developments

            12.3.11.5. Market Strategy

        12.3.12. Aurigene Pharmaceutical Services Ltd.

            12.3.12.1. Overview

            12.3.12.2. Segments and Products

            12.3.12.3. Key Financials

            12.3.12.4. Market Developments

            12.3.12.5. Market Strategy

        12.3.13. Creative Biogene

            12.3.13.1. Overview

            12.3.13.2. Segments and Products

            12.3.13.3. Key Financials

            12.3.13.4. Market Developments

            12.3.13.5. Market Strategy

        12.3.14. Lonza

            12.3.14.1. Overview

            12.3.14.2. Segments and Products

            12.3.14.3. Key Financials

            12.3.14.4. Market Developments

            12.3.14.5. Market Strategy

        12.3.15. System Biosciences, LLC

            12.3.15.1. Overview

            12.3.15.2. Segments and Products

            12.3.15.3. Key Financials

            12.3.15.4. Market Developments

            12.3.15.5. Market Strategy

            12.3.16. Vernal Biosciences

        12.3.16.1. Overview

            12.3.16.2. Segments and Products

            12.3.16.3. Key Financials

            12.3.16.4. Market Developments

            12.3.16.5. Market Strategy

        12.3.17. RiboPro

            12.3.17.1. Overview

            12.3.17.2. Segments and Products

            12.3.17.3. Key Financials

            12.3.17.4. Market Developments

            12.3.17.5. Market Strategy

        12.3.18. Syngene International Limited

            12.3.18.1. Overview

            12.3.18.2. Segments and Products

            12.3.18.3. Key Financials

            12.3.18.4. Market Developments

            12.3.18.5. Market Strategy

        12.3.19. BioNTech i

            12.3.19.1. Overview

            12.3.19.2. Segments and Products

            12.3.19.3. Key Financials

            12.3.19.4. Market Developments

            12.3.19.5. Market Strategy

        12.3.20. Samsung Biologics

            12.3.20.1. Overview

            12.3.20.2. Segments and Products

            12.3.20.3. Key Financials

            12.3.20.4. Market Developments

            12.3.20.5. Market Strategy

        12.3.21. Recipharm AB

            12.3.21.1. Overview

            12.3.21.2. Segments and Products

            12.3.21.3. Key Financials

            12.3.21.4. Market Developments

            12.3.21.5. Market Strategy

        12.3.22. Catalent, Inc 

            12.3.22.1. Overview

            12.3.22.2. Segments and Products

            12.3.22.3. Key Financials

            12.3.22.4. Market Developments

            12.3.22.5. Market Strategy

        12.3.23. AGC Biologics

            12.3.23.1. Overview

            12.3.23.2. Segments and Products

            12.3.23.3. Key Financials

            12.3.23.4. Market Developments

            12.3.23.5. Market Strategy

13. Appendix

    13.1. Research Methodology

    13.2. Research Assumptions

    13.3. Acronyms and Abbreviations

List Of Table

- List Of Chart -